The federal DC circuit court on Tuesday (May 21) ruled the 340B drug discount law does not prohibit drug makers from limiting the number of contract pharmacies that can distribute discounted drugs to covered entities, marking another favorable decision for the drug industry and a setback for 340B hospitals. Since 2020 several drug makers have imposed restrictions on 340B drug discounts to combat what they allege are duplication and diversion issues in the program. The appeals court ruled that the...